Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market
Holding TRVI?
Track your performance easily

Trevi Therapeutics (TRVI) Financial Statements

304 Followers

Trevi Therapeutics Financial Overview

Trevi Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.387; its P/E ratio is -8.87; Trevi Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -12.36M$ -10.91M$ -7.80M$ -7.71M$ -7.02M
EBITDA$ -11.83M$ -10.87M$ -7.76M-$ -7.38M
Net Income Common Stockholders$ -12.35M$ -10.90M$ -7.82M$ -7.70M$ -7.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 69.50M$ 72.82M$ 82.97M$ 88.87M$ 94.15M
Total Assets$ 73.81M$ 78.56M$ 89.40M$ 95.90M$ 100.98M
Total Debt$ 1.19M$ 1.27M$ 1.34M$ 1.41M$ 1.47M
Net Debt$ -68.30M$ -71.55M$ -81.63M$ -87.46M$ -92.68M
Total Liabilities$ 7.64M$ 6.22M$ 6.86M$ 6.29M$ 5.90M
Stockholders Equity$ 66.17M$ 72.33M$ 82.55M$ 89.61M$ 95.07M
Cash Flow-
Free Cash Flow$ -8.71M$ -10.47M$ -6.38M-$ -9.91M
Operating Cash Flow$ -8.68M$ -10.47M$ -6.36M$ -7.28M$ -9.88M
Investing Cash Flow$ 2.77M$ -8.09M$ 12.85M$ 17.98M$ 19.64M
Financing Cash Flow$ 5.07M$ -28.00K$ -54.00K$ 1.51M$ -7.66M
Currency in USD

Trevi Therapeutics Earnings and Revenue History

Trevi Therapeutics Debt to Assets

Trevi Therapeutics Cash Flow

Trevi Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis